Hunter C. Smith — Director at Genesee & Wyoming

Mr. Hunter C. Smith has been Chief Financial Officer and Treasurer of Rhythm Pharmaceuticals, Inc. since July 2017 and August 2017 respectively. Mr. Smith has been the Chief Financial Officer of Rhythm Holding Company, LLC since August 1, 2017. He has over 20 years of global finance and management experience across multiple industries and financial disciplines, including expertise in business analysis and planning, mergers and acquisitions, capital raising and investor relations. Mr. Smith served as Vice President of Finance and Chief Financial Officer of the Inflammation and Immunology Business Unit of Celgene Corporation from 2013 to July 2017. Mr. Smith provided finance leadership for the global launch of Otezla???, co-led the integration of Receptos, Inc. following its acquisition by Celgene and led global business planning and analysis for commercial affiliates and clinical study activities in over 16 countries. He held various roles during a 14-year tenure (1999 to 2013) at Bunge Limited, including Chief Financial Officer of two distinct business units, Corporate Treasurer and Chief Risk Officer. He served as Regional Chief Financial Officer for Asia at Bunge Limited since July 21, 2003 and its Director of Investor Relations and Global Communications. He served as the Chief Financial Officer of Bunge's Sugar and Bioenergy Segment. He joined Bunge in 1998 as Assistant Treasurer. He started his career at Manufacturers Hanover Trust Company. He has been an Independent Director of Genesee & Wyoming Inc. since March 27, 2015. He served as a Director of UBS AG. Mr. Smith has a BA in History from Northwestern University and MBA in Finance from the Stern School of Business at New York University.